This week’s newsletter is Sponsored By: Milliman Irix Enroll

Slash call times and close more business Milliman Irix Enroll

Here is what you’ll find in this week’s newsletter!

  1. Important links 🔗 - the best articles we found this week about the Medicare Market along with links to Jared’s recent LinkedIn posts.

  2. Deep Dive 📚 - eBroker CY 2025 Results: Side-By-Side

  3. Sponsor Snapshot 🚀 - brought to you by Milliman Irix Enroll

It’s only a 5 minute read, but it will make you 10x smarter.

Here are IMPORTANT LINKS 🔗 for the week:

  1. CMS Ups Pay for Medicare Advantage Plans by 2.48% in 2027 - (link)

  2. Chris Klomp: 2027 MA final rate notice, accountable relationships, and opportunity for startups - (link)

  3. Important Update: Medicare Advantage and PDP Offerings- (link)

  4. Hospice where staggering 97% of terminal patients survive is accused of defrauding Medicare for $7.45 million- (link)

  5. Gyde Acquires Medicare Agency Avid Health To Expand Across Medicare Markets - (link)

  6. Medicare Beneficiaries to See Simpler and More Flexible Plan Choices, Better Drug Coverage, Higher Quality and Lower Costs in 2027 - (link)

  7. Red ink at Minnesota Blue Cross spells more Medicare Advantage troubles ahead - (link)

  8. Medicare Supplement Broker Incentives - 2026 Q2 Update - (link)

Jared’s recent LinkedIn posts:

  1. $511 Billion. Public Traded MA Carriers - (link)

  2. Regulatory updates for the month of April - (link)

  3. MA revenue is expected to increase $13 billion in 2027 - (link)

  4. MA Rate Announcement dropped - (link)

DEEP DIVE 📚

eBroker CY 2025 Results: Side-By-Side

This week, we’re digging into Calendar Year (“CY”) 2025 financials for publicly traded Direct-to-Consumer distributors → the “eBrokers.”

The three we’ll compare are:

(CY 2024 is here)

Company Commentary

Before comparing these 3 companies, it’s worth mentioning some notable commentary to help provide context for CY 2025 results.

GOCO strategically pulled back.

  • GoHealth intentionally reduced Medicare Advantage volume in 2025 due to pressures in the MA space (link)

  • GOCO also reported $260 million in impairment charges related to indefinite-lived assets.

    • For comparability, this impairment is excluded from the operating expense figures below.

EHTH and SLQT did not strategically pull back

It’s also worth noting that there are Two other big players who don’t break out segment financials:

  • HealthMarkets (UnitedHealth Group)

  • Innovative Financial Group (Humana)

Side-By-Side Results

To compare and contrast CY 2025 results we are looking at the Income Statement, a few key Balance Sheet items, LTV metrics, and Sales metrics.

Notes:

  1. GOCO Income Statement excludes $260 million “Indefinite and long-lived asset impairment charges”

Key Takeaways:

  • SLQT led in total revenue, and overhead efficiency.

  • EHTH reported the highest Medicare Advantage LTV at $1,154.

  • EHTH also maintained the lowest debt load.

  • SLQT led in sales volume, adding 644,000+ approved policies.

  • All three carried between a $925 million and $1.25 billion in Commission Receivables.

YoY % Change

Let’s observe and discuss the year-over-year (“YoY”) % changes.

Revenues

  • EHTH increased Commission Revenue 8%

  • SLQT Commission Revenue decreased, but Other Revenue increased significantly, resulting in the largest overall Revenue increase of 11%

  • GOCO strategically decreased sales resulting in a large drop in Revenue.

Expenses

  • EHTH expenses decreased slightly

  • GOCO expenses decreased significantly due to strategically pulling back on new sales

    • Note: this ignores the $260 million Indefinite and long-lived asset impairment charges expense

  • SLQT expenses increased, driven by an increase in Cost of Goods Sold for the Healthcare segment which was due to significant volume growth.

Profitability (Loss)

  • EHTH improved profitability the most among the 3.

  • SLQT decrease in profitability was largely driven by a lower margin on the Healthcare business.

  • GOCO profitability suffered, due to strategic pullback.

Balance Sheet Changes

  • Commission Recievable balances rose a combined 2%.

  • SLQT cut long-term debt –43%, a major deleveraging move.

  • GOCO increased long-term debt 31%.

  • EHTH increased long-term debt 65%, but continues to hold the lowest Debt load.

LTV Changes

  • Medicare Advantage LTV is down overall.

  • EHTH MA LTV increased, while GOCO and SLQT saw a lower MA LTV.

Sales

  • Overall sales fell –25% YoY, driven by GOCO’s strategic pull-back.

  • SLQT’s SelectRx customers grew +17% YoY

Reporting Note: GOCO reports submitted policies; SLQT and EHTH report approved policies.

Bottom Line

The three public eBrokers each had a unique story in CY 2025.

GOCO made a deliberate choice to pull back on MA volume, which drove the revenue decline but also meaningfully reduced expenses.

EHTH grew commission revenue and improved profitability year-over-year, while keeping its debt load the lowest of the three. MA LTV was the standout metric. Highest among the group at $1,154.

SLQT led on total revenue, sales volume, and overhead efficiency, and made a significant balance sheet move by cutting long-term debt 43%. The Healthcare segment was both the growth driver and the margin headwind. SelectRx volume growth came with higher costs that weighed on overall profitability.

Across all three, MA LTV declined or held flat, a trend worth watching as the industry heads into SEP periods and on into AEP 2027.

Slash call times and close more business with instant access to Rx data.

Irix Enroll is a game changer for Medicare brokers, carriers, and customers.

It shaves up to eight minutes off average handle times and makes the annual enrollment period easier for applicants and agents alike.

Irix Enroll instantly gathers an applicant’s prescription and provider history—no need to rely on individuals to collect and read their drug information from bottles and packets or manually enter the details. And whether your model is agent-assist or DTC, it quickly guides enrollees to the best and most cost-effective plan to help you close more business.

  • Reduce average handle time on the phone

  • Decrease application burden

  • Improve consumer and plan retention

  • Assist with provider identification and confirmation of network status

  • Increase sales, close ratios, and commissions

  • Deliver a better enrollment experience

Request a demoIrix Enroll

What MMI + Subscribers read this week…

  • Insurance Regulatory Insights April 2026 - 🎂Birthday Rules coming to NM and WV. (link)

  • March ‘26 MA/MAPD and PDP enrollment data - February enrollment data has been loaded. Here are a few observations. (link)

  • Broker/Agent MA Commissions Increasing in 2027 - A look at historical MA/MAPD agent comp., and what to expect in 2027. (link)

Receive regulatory updates with the Insurance Regulatory Insights newsletter.

  • Monthly newsletters providing insight into recent insurance regulatory action

  • Access to Reg Tracker, a comprehensive list of insurance regulatory actions in all states for this calendar year that are included in the newsletters.

Insurance Regulatory Insights is now included in your MMI+ subscription! You can also subscribe using the link below.

How was today's newsletter?

Login or Subscribe to participate

If you’re ready, here are some ways we can help you:

  • Newsletter Sponsorship opportunities: Promote your product or services to leaders in the Medicare space. Let’s discuss. (link)

  • Market Research: Reports that help you wrap your arms around the Senior focused insurance markets. (link)

  • Consulting: We can help you develop new insurance products for the Medicare market, appraise your books of business, and keep you compliant. Let’s discuss. (link)

Did this get forwarded to you? Get the Medicare Market Insights newsletter sent directly to your email weekly: